HoehnsJDFoutsMMKellyMWTuKB. Sudden cardiac death with clozapine and sertraline combination. Ann Pharmacother2001; 35: 862–6.
2.
HallerCABenowitzNL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med2000; 343: 1833–8.
3.
HarbisonJO'ReillyPMcNicholasWT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: Effects of nasal continuous positive airway pressure therapy. Chest2000; 118: 591–5.
4.
MaronBJ. Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy. Curr Cardiol Rep2000; 2: 522–8.
5.
SpiritoPBellonePHarrisKMBernaboPBruzziPMaronBJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med2000; 342: 1778–85.
6.
Valencia-FloresMOreaACastañoVAResendizMRosalesMRebollarV. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res2000; 8: 262–9.
7.
WienerITilkianAGPalazzoloM. Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: Temporal relationship to pseudoephedrine ingestion. Cathet Cardiovasc Diagn1990; 20: 51–3.
AminMLehmannHMirmiranJ. A double-blind, placebo-controlled dose-finding study with sertraline. Psychopharmacol Bull1989; 25: 164–7.
10.
GlassmanAO'ConnorCMHarrisonW. Sertraline treatment of major depression in patients with acute MI or unstable angina (poster). Presented at American Psychiatric Association Annual Meeting, New Orleans, LA, May 5–10, 2001.
11.
SchneiderLFriedhoffAJKrishnanKRRClaryCM. A double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression (poster). Presented at American Psychiatric Association Annual Meeting, Chicago, IL, May 13–18, 2000.
12.
Data on file. New York: Pfizer.
13.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.